Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
종목 코드 SNOA
회사 이름Sonoma Pharmaceuticals Inc
상장일Jan 26, 2007
CEOMs. Amy Trombly
직원 수168
유형Ordinary Share
회계 연도 종료Jan 26
주소5445 Conestoga Court, Suite 150
도시BOULDER
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호80301
전화18007599305
웹사이트https://sonomapharma.com/
종목 코드 SNOA
상장일Jan 26, 2007
CEOMs. Amy Trombly
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음